Does SECUKINUMAB Cause Peripheral venous disease? 1,186 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,186 reports of Peripheral venous disease have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.8% of all adverse event reports for SECUKINUMAB.
1,186
Reports of Peripheral venous disease with SECUKINUMAB
0.8%
of all SECUKINUMAB reports
1,036
Deaths
1,072
Hospitalizations
How Dangerous Is Peripheral venous disease From SECUKINUMAB?
Of the 1,186 reports, 1,036 (87.4%) resulted in death, 1,072 (90.4%) required hospitalization, and 1,075 (90.6%) were considered life-threatening.
Is Peripheral venous disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 1,186 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Peripheral venous disease?
RITUXIMAB (1,281)
ADALIMUMAB (1,249)
METHOTREXATE (1,246)
ABATACEPT (1,168)
DICLOFENAC (1,168)
LEFLUNOMIDE (1,154)
TOCILIZUMAB (1,137)
PREDNISONE (1,101)
ALENDRONATE (1,097)
INFLIXIMAB (1,091)
Which SECUKINUMAB Alternatives Have Lower Peripheral venous disease Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG